New England Research & Management Inc. Takes $1.25 Million Position in Astera Labs, Inc. $ALAB

Key Points

• New England Research & Management Inc. has acquired a $1.25 million stake in Astera Labs, Inc. by purchasing 13,825 shares in the second quarter.
• Astera Labs reported a strong quarterly earnings result with an EPS of $0.44, exceeding analyst expectations, while revenue increased by 149.5% year-over-year.
• Several analysts have raised their price targets for Astera Labs, with Deutsche Bank increasing theirs to $200.00, indicating a positive outlook for the stock.

New England Research & Management Inc. acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 13,825 shares of the company's stock, valued at approximately $1,250,000.

A number of other large investors also recently bought and sold shares of ALAB. GAMMA Investing LLC lifted its holdings in shares of Astera Labs by 55.7% in the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after buying an additional 284 shares during the period. Sound Income Strategies LLC lifted its stake in shares of Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after purchasing an additional 204 shares during the last quarter. Harbour Investments Inc. increased its position in Astera Labs by 351.7% during the 1st quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after buying an additional 619 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new position in Astera Labs during the 1st quarter valued at about $48,000. Finally, Hazlett Burt & Watson Inc. increased its position in Astera Labs by 1,670.0% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock valued at $53,000 after buying an additional 835 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Trading Up 0.8%

NASDAQ:ALAB opened at $231.29 on Tuesday. The firm has a market cap of $38.45 billion, a PE ratio of 413.02, a price-to-earnings-growth ratio of 5.82 and a beta of 1.46. The stock has a fifty day moving average price of $157.95 and a 200 day moving average price of $105.12. Astera Labs, Inc. has a 12-month low of $42.80 and a 12-month high of $237.82.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. The company had revenue of $191.93 million during the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.Astera Labs's revenue for the quarter was up 149.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other news, COO Sanjay Gajendra sold 91,441 shares of Astera Labs stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief operating officer owned 2,170,877 shares in the company, valued at approximately $398,377,638.27. The trade was a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jack R. Lazar sold 22,500 shares of the business's stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total value of $4,014,450.00. Following the completion of the transaction, the director owned 97,351 shares in the company, valued at $17,369,365.42. This trade represents a 18.77% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,725,979 shares of company stock valued at $254,102,940. 12.50% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on ALAB shares. Deutsche Bank Aktiengesellschaft increased their price objective on Astera Labs from $160.00 to $200.00 and gave the company a "buy" rating in a report on Tuesday, September 2nd. Needham & Company LLC increased their price target on Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Morgan Stanley raised their target price on Astera Labs from $155.00 to $200.00 and gave the company an "overweight" rating in a research report on Friday, August 29th. Wall Street Zen raised Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday, August 16th. Finally, Susquehanna increased their price target on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $142.00.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.